| G |
|
G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN1 (GIT1) IS TYROSINE-PHOSPHORYLATED DOWNSTREAM OF INTEGRIN ALPHA IIB BETA3 IN PLATELETS
|
| Sato H., Suzuki-Inoue K., Inoue O., Ozaki Y. |
| |
|
G20210A PROTHROMBIN MUTATION IS MORE FREQUENT IN PATIENTS WITH ADVANCED STAGES OF PERIPHERAL ARTERIAL DISEASE (PAD)
|
| Favaretto E., Legnani C., Conti E., Pili C., Filippini M., Palareti G. |
| |
|
GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
|
| Schattner M., Pacienza N., Pozner R.G., Bianco G.A., D'Atri L.P., Negrotto S., Malaver E., Gomez R.M., Rabinovich G.A. |
| |
|
GALLIC ACID BLUNTS PLATELET INHIBITION BY ASPIRIN AND OTHER POLYPHENOLS: IMPLICATIONS FOR THE ANTITHROMBOTIC PROPERTIES OF ASPIRIN AND DIETARY POLYPHENOLS
|
| Crescente M., Cerletti C., de Gaetano G. |
| |
|
GAMMA-GLUTAMYL CARBOXYLASE-DEPENDENT SECRETION OF PROTEIN Z
|
| Souri M., Zhang W., Iwata H., Sugawara H., Ichinose A. |
| |
|
GASTROINTESTINAL BLEEDING DUE TO MECKEL'S DIVERTICULUM IN A HEMOPHILIAC WITH INHIBITORS
|
| Koh P.L., Prabhakaran K., Quah T.C. |
| |
|
GENDER AND MENSTRUAL CYCLE INFLUENCE CIRCULATING MICROPARTICLES
|
| Toth B., Nikolajek K., Rank A., Friese K., Thaler C.J., Nieuwland R. |
| |
|
GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
|
| Kim N., Park H., Kim O., Bae S., Hong S., Oh D., Yoon H., Park S. |
| |
|
GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
|
| Giusti B., Rossi L., Lapini I., Magi A., Capalbo A., Boddi M., Abbate R., Marini M., Samaya M., Vecsteinas A. |
| |
|
GENE EXPRESSION PROFILING IDENTIFIES C/EBP-DELTA AS A CANDIDATE REGULATOR OF ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
|
| Slofstra S.H., Groot A.P., Reitsma P.H., ten Cate H., Spek C.A. |
| |
|
GENERATION AND CHARACTERIZATION OF A RECOMBINANT BLOCKING ANTI-GLYCOPROTEIN VI SINGLE CHAIN ANTIBODY FRAGMENT
|
| Muzard J., Minullina I., Loyau S., Billiald P., Jandrot-Perrus M. |
| |
|
GENERATION AND EXPRESSION OF RECOMBINANT FACTOR XIII-B MUTANTS
|
| Balogh I., Dzsudzsak E., Ajzner E., Fekete A., Csapo A., Kappelmayer J. |
| |
|
GENERATION OF CARBOXYPEPTIDASE U (TAFIA) IN ISCHEMIC STROKE PATIENTS RECEIVING THROMBOLYTIC THERAPY
|
| Willemse J.L., Brouns R., Heylen E., Sheorajpanday R., Kunnen J., De Deyn P.P., Hendriks D.F. |
| |
|
GENERATION OF INTERMEDIATE AFFINITY FORMS OF 2 I DOMAIN
|
| Hamaia S.W., Siljander P.R.M., Orf K., Bihan D., Williams J., Raynal N., Farndale R.W. |
| |
|
GENERIC VERSIONS OF BRANDED LOW MOLECULAR WEIGHT HEPARINS CAN BE DIFFERENTIATED IN BIOLOGIC AND PHARMACOLOGIC ASSAYS
|
| Jeske W.P., Ackerman P., Drenth A., Walenga J., Bakhos M. |
| |
|
GENETIC ABLATION OF JAM-A IMPAIRS SURVIVAL AFTER MYOCARDIAL INFARCT
|
| Cooke V.G., Gao E., Tsuda T., Naik U.P. |
| |
|
GENETIC ANALYSIS BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION IN PROTEIN S DEFICIENCY
|
| Garcia A.A., Borgel D., Alhenc-Gelas M., Spek C., Gandrille S., Reitsma P.H. |
| |
|
GENETIC ANALYSIS IN HYPOFIBRINOGENEMIA IN ELEVEN FAMILIES
|
| Hill M., Hanley J., Maclean R., Garipidou V., Tait R., Dolan G. |
| |
|
GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
|
| Giusti B., Saracini C., Bolli P., Sestini I., Sticchi E., Magi A., Pratesi G., Pulli R., Pratesi C., Abbate R. |
| |
|
GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
|
| Kazemi A., Taghavi A., Rassoulzadegan M., Ravanbod S., Faranoush M., Jazebi M., Baghaipour M., Ala F.A., Rastegar Lari G. |
| |
|
GENETIC ANALYSIS OF HEREDITARY PROTEIN S DEFICIENCY IN TWO CHINESE PEDIGREES
|
| Yang F., Jin P., Wang X., Wang H. |
| |
|
GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
|
| Rastegar Lari G., Tamaddon G., Eshghi P., Hejazi S., Ravanbod S., Kazemi A., Rassoulzadegan M., Baghaipour M., Jazebi M., Faranoush M., Tabatabaey A., Enayat M.S., Ala F.A. |
| |
|
GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
|
| Evangelisti L., Attanasio M., Sofi F., Pepe G., Marcucci R., Fatini C., Valente S., Giglioli C., Abbate R., Gensini G.F. |
| |
|
GENETIC AND ENVIRONMENTAL RISK FACTORS FOR FVIII INHIBITOR DEVELOPMENT
|
| Astermark J. |
| |
|
GENETIC BASIS OF ACQUIRED HAEMOPHILIA
|
| Pavlova A., Oldenburg J. |
| |
|
GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN
|
| Artoni A., Afrabiasi A., Lecchi A., Karimi M., Ashouri E., Peyvandi F., Mannucci P.M. |
| |
|
GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
|
| Hu S., Chen Y., Cheng S., Chao T., Tsai W., Chiang J., Huang S. |
| |
|
GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
|
| Hu S., Chen Y., Cheng S., Chao T., Tsai W., Chiang J., Huang S. |
| |
|
GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
|
| Viel K.R., Wu J., Chung D.W., Fujikawa K., Cole S.A., Dyer T.D., Mahaney M.C., McMullen B., MacCluer J.W., Blangero J.C., Almasy L.A., Howard T.E. |
| |
|
GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
|
| Souto J.C., Pujol N., Buil A., Almasy L., Nomdedeu J., Simón M., Blangero J., Fontcuberta J., Soria J.M. |
| |
|
GENETIC FACTORS FOR DETERMINATION OF PLASMA VWF LEVELS IN A GENERAL POPULATION
|
| Yabe M., Matsubara Y., Takahashi S., Ishihara H., Shibano T., Watanabe G., Murata M., Ikeda Y. |
| |
|
GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL
|
| González-Conejero R., Corral J., Roldán V., Ferrer F., Sanchez-Blanco J., Sanchez I., Garcia-Barberá N., Vicente V. |
| |
|
GENETIC MODIFICATION OF A SPECIES-DIVERGENT BOND IN VWF-A1 PEMITS HUMAN PLATELET THROMBUS FORMATION IN MICE
|
| Chen J., Tan K., Zhao H., Lo H., Liddington R.C., Diacovo T.G. |
| |
|
GENETIC POLYMORPHISM OF THE PLATELET ADP-RECEPTOR P2Y12 MODIFIES THE RISK OF PULMONARY EMBOLISM IN PATIENTS WITH DEEP-VEIN THROMBOSIS
|
| Kapustin S.I., Klenkova N.A., Kobilyanskaya V.A., Saltykova N.B., Kargin V.D., Papayan L.P., Blinov M.N. |
| |
|
GENETIC POLYMORPHISM R353Q OF FACTOR VII HAS PROTECTIVE EFFECT IN THREATENED MISCARRIAGE
|
| Nikitina L.A., Sadekova O.N., Azarova O.Y., Demidova E.M., Bochkov V.N., Samokhodskaya L.M. |
| |
|
GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
|
| Banno M., Hanada H., Kamide K., Kokubo Y., Kada A., Yang J., Tanaka C., Takiuchi S., Horio T., Matayoshi T., Yasuda H., Nagura J., Tomoike H., Kawano Y., Miyata T. |
| |
|
GENETIC THROMBOPHILIA AND THROMBOSIS OF CEREBRAL VENOUS SINUSES
|
| Romero A., Marco P., Sanchez S., Verdu J.J. |
| |
|
GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
|
| Bezemer I.D., Doggen C.J.M., Arellano A.R., Young B.A., Reitsma P.H., Rosendaal F.R., Bare L.A. |
| |
|
GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS ENCODING PORCINE FACTOR VIII INDUCE PROCOAGULANT ACTIVITY IN HEMOPHILIA A MICE WITH PRE-EXISTING FACTOR VIII IMMUNITY
|
| Doering C.B., Gangadharan B., Dukart H., Spencer H.T. |
| |
|
GENOMIC AND STRUCTURAL ANALYSIS OF THE PROTECTIVE EFFECTS OF ACTIVATED PROTEIN C IN A BABOON MODEL OF E. COLI SEPSIS
|
| Zhu H., Silasi-Mansat R., Ivanciu L., Georgescu C., Taylor F.B., Lupu C., Lupu F. |
| |
|
GIANT PLATELET DISORDERS
|
| Balduini C.L. |
| |
|
GIESSEN THROMBOPHILIA STUDY: MANIFESTATION AGE OF THROMBOEMBOLISM IN THROMBOPHILIA
|
| Kemkes-Matthes B., Nees M., Fischer R. |
| |
|
GLOBAL ASSAY USING CLOT WAVEFORM AND THROMBIN GENERATION ASSAY
|
| Shima M. |
| |
|
GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
|
| Hayward C.P.M., Whittaker S., Liu Y., Pai M., Arnold E., Moffat K.A., Seecharan J., Webert K.E., Cook R.J., Heddle N.M. |
| |
|
GLYCINE AND LYS-PRO-ARG-GLY: POSSIBLE MECHANISMS OF ACTION ON FIBRINOLYTIC AND ANTICOAGULANT ACTIVITY
|
| Grigorjeva M.E., Obergan T.Y. |
| |
|
GLYCOGEN SYNTHASE KINASE-3 NEGATIVELY REGULATES TISSUE FACTOR GENE EXPRESSION IN MONOCYTES INTERACTING WITH ACTIVATED PLATELETS
|
| Di Santo A., Amore C., Martelli N., Manarini S., Evangelista V. |
| |
|
GLYCOPROTEIN IB ALPHA BINDS THROMBIN VIA TO BOTH EXOSITE I AND II OF THROMBIN
|
| Yegneswaran S., McClintock R., Roberts J., Ruggeri Z.M. |
| |
|
GLYCOPROTEIN Ib MEDIATES PLATELET RECRUITMENT, ACTIVATION AND AGGREGATION ON IMMOBILIZED PROTEIN C AND ACTIVATED PROTEIN C UNDER SHEAR
|
| White T.C., Berny M.A., Fernández J.A., Griffin J.H., Gruber A., McCarty O.J.T. |
| |
|
GLYCOPROTEIN IB-ALPHA CONTRIBUTES TO TISSUE FACTOR-INDEPENDENT THROMBIN GENERATION BY RECOMBINANT FACTOR VIIA ON THE ACTIVATED PLATELET SURFACE
|
| Weeterings C., Adelmeijer J., de Groot P.G., Lisman T. |
| |
|
GLYCOPROTEIN IIB/IIIA RECEPTOR DENSITY MEASUREMENT. IMPLICATIONS IN THE MONITORING OF ANTIPLATELET DRUGS
|
| Iqbal O.M., Parks T., Hoppensteadt D., Fareed J. |
| |
|
GLYCOSYLATION OF THE ACTIVATION PEPTIDE OF FACTOR IX DETERMINES PLASMA HALF-LIFE
|
| Chang J.Y., Brock J., Griffith M.J., Monroe D.M. |
| |
|
GPIIB-IIIA ANTAGONISTS HAVE A SIGNIFICANT EFFECT ON THROMBUS STABILITY BY DISPLACING BOUND FIBRINOGEN
|
| Jennings L.K., White M.M., Kueter T.J., Speich H.E., Hill S.N., Earhart A.D., Slack S.M. |
| |
|
GPIIB-IIIA INTEGRIN MUTATIONS IDENTIFIED IN 19 GLANZMANN THROMBASTENIC PATIENTS AND 3 CARRIERS
|
| Jallu V., Kaplan C. |
| |
|
GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
|
| Gladigau E.L., Smethurst P.A., Groot E., James T.E., Farndale R.W., Fijnheer R., Goodall A.H., De Groot P.G., Ouwehand W.H. |
| |
|
GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT)
|
| Camporese G., Bernardi E., Prandoni P., Noventa F., Verlato F., Cordova R., Simioni P., Andreozzi G.M. |
| |
|
GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
|
| Siegbahn A., Braun O., Johnell M., Varenhorst C., James S., Brandt J.T., Jakubowski J.A., Winters K.J., Erlinge D., Wallentin L. |
| |
|
GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
|
| Siegbahn A., Jakubowski J.A., Braun O., Varenhorst C., James S., Johnell M., Brandt J.T., Sugidachi A., Winters K.J., Erlinge D., Wallentin L. |
| |
|
GTP-INDUCED DENSE GRANULE SECRETION IN PLATELETS IS MEDIATED BY RAL-EXOCYST PATHWAY
|
| Kawato M., Shirakawa R., Kondo H., Higashi T., Ikeda T., Kita T., Horiuchi H. |
| |
|
GYNAECOLOGICAL AND OBSTETRICAL PROBLEMS IN WOMEN AFFECTED WITH INHERITED BLEEDING DISORDERS
|
| Siboni S.M., Calò L., Santagostino E., Mancuso M.E., Gianniello F., Federici A.B., Peyvandi F. |
| |
|
GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY
|
| Batorova A., Schved J., Auerswald G., Herrmann F., Peyvandi F., Dolce A., Bernardi F., Mariani G. |
| |
